| 000 | 01743nam a22004578a 4500 | ||
|---|---|---|---|
| 005 | 20250919010757.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 160223r2010||||enk s ||1 0|eng|d | ||
| 020 | _a9780511730412 (ebook) | ||
| 020 | _z9780521887236 (hardback) | ||
| 020 | _z9781107475915 (paperback) | ||
| 035 | _a(OCoLC)813438538 | ||
| 035 | _a(UkCbUP)CR9780511730412 | ||
| 039 | 9 |
_y02-23-2016 _zafifah |
|
| 040 |
_aUkCbUP _cUkCbUP _erda |
||
| 090 | _aebook PHCTM | ||
| 245 | 0 | 0 |
_aDrug Design : _bStructure- and Ligand-Based Approaches / _cEdited by Kenneth M. Merz, Jr, Dagmar Ringe, Charles H. Reynolds. |
| 264 | 1 |
_aCambridge : _bCambridge University Press, _c2010. |
|
| 300 |
_a1 online resource (286 pages) : _bdigital, PDF file(s). |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aTitle from publisher's bibliographic system (viewed on 28 Apr 2015). | ||
| 650 | 0 |
_aDrugs _xDesign. |
|
| 650 | 0 |
_aDrugs _xStructure-activity relationships. |
|
| 650 | 0 | _aDrug Design. | |
| 650 | 0 | _aLigands. | |
| 650 | 0 | _aStructure-Activity Relationship. | |
| 700 | 1 |
_aMerz, Jr, Kenneth M., _eeditor of compilation. |
|
| 700 | 1 |
_aRinge, Dagmar, _eeditor of compilation. |
|
| 700 | 1 |
_aReynolds, Charles H., _eeditor of compilation. |
|
| 776 | 0 | 8 |
_iPrint version: _z9780521887236 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1017/CBO9780511730412 |
| 856 | 4 | 0 | _uhttps://www.cambridge.org/core/books/drug-design/0C3547F488E3233449DA1B3D81AA30D2 |
| 907 |
_a.b16278276 _b2023-06-28 _c2019-11-12 |
||
| 942 |
_n0 _kebook PHCTM |
||
| 914 | _avtls003600951 | ||
| 998 |
_ae _b2016-10-02 _cm _dz _feng _genk _y0 _z.b16278276 |
||
| 999 |
_c605450 _d605450 |
||